Expression of matrix metalloproteinases-2 and -9 by cells isolated from the peritoneal fluid of women with ovarian carcinoma

Acta Cytologica

Volumn 46, Issue 4, 2002, Pages 697-703

  Sakata, Kenichirou ^a   Shigemasa, Kazushi ^a   Uebaba, Yoshimi ^a   Nagai, Nobutaka ^a   Ohama, Koso ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Matrix metalloproteinases; Ovarian cancer; Peritoneal fluid

Indexed keywords

GELATINASE A; GELATINASE B;

ARTICLE; ASCITES FLUID CYTOLOGY; CANCER CELL; CANCER GRADING; CANCER STAGING; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MESOTHELIUM CELL; OVARY CARCINOMA; PERITONEAL FLUID; PRIORITY JOURNAL; PROTEIN EXPRESSION;

FALLOPIA;

EID: 0036076355     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Ovarian cancer
2. Cancer statistics
3. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
4. Tumor invasion and metastasis: An imbalance of positive and negative regulation
5. Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix
6. Immunohistochemical distribution of type IV collagenase in normal, benign and malignant breast tissue
7. Evaluation of basement membrane components and the 72-kDa type IV collagenase in serous tumors of the ovary
8. Metastatic potential correlates with enzymatic degradation of basement membrane collagen
9. Expression of type IV collagenase and procollagen genes and its correlation with the tumorigenic, invasive, and metastatic abilities of oncogene-transformed human bronchial epithelial cells
10. Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer
11. Activity of type IV collagenases in benign and malignant breast disease
12. Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion
13. Immunohistochemical studies on matrix metalloproteinase-9 (MMP-9) and type IV collagen in endometrial carcinoma
14. Mr 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer
15. Expression of 72 kilodalton type IV collagenase (gelatinase A) in benign and malignant ovarian tumors
16. Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumor cell lines
17. Section of extracellular matrix-degrading proteinases is increased in epithelial ovarian carcinoma
18. Gelatinase A-immunoreactive protein in ovarian lesions: Prognostic value in epithelial ovarian cancer
19. Changes in definitions of clinical staging for carcinoma of the cervix and ovary
20. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary
21. Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP-2) in stage I and II endometrial cancer
22. Characterization of gelatinases linked to extracellular matrix invasion in ovarian adenocarcinoma: Purification of matrix metalloproteinase 2
23. Distinction between carcinoma cells and mesothelial cells in serous effusions: Usefulness of immunohistochemistry
24. Immunohistochemical differentiation of reactive mesothelial cells and adenocarcinoma cells in serous effusions with the use of carcinoembryonic antigen and fibronectin
25. Use of E-cadherin and CD44 aids in the differentiation between reactive mesothelial cells and carcinoma cells in pelvic washings